William C. Mobley
Affiliations: | Neurology | University of California, San Diego, La Jolla, CA |
Area:
neurodegneration, Down syndromeGoogle:
"William Mobley"Bio:
William C. Mobley, MD, PhD is a clinician and researcher who is internationally known for his work on degenerative diseases of the central nervous system and the neurobiology of Down syndrome.
Mean distance: 15.07 (cluster 40)
Children
Sign in to add traineeCharles L. Howe | grad student | 2000 | UCSF |
April M. Weissmiller | grad student | 2013 | UCSD |
David M. Holtzman | post-doc | UCSF | |
Ahmad Salehi | post-doc | Stanford Medical School/Palo Alto VA |
Collaborators
Sign in to add collaboratorAhmad Salehi | collaborator | 1999-2010 | Stanford Medical School/Palo Alto VA |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Sawa M, Overk C, Becker A, et al. (2021) Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
Chen XQ, Salehi A, Pearn ML, et al. (2020) Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
Johnstone A, Mobley W. (2020) Local TrkB signaling: themes in development and neural plasticity. Cell and Tissue Research. 382: 101-111 |
Qian H, Kang X, Hu J, et al. (2020) Author Correction: Reversing a model of Parkinson's disease with in situ converted nigral neurons. Nature |
Stupack J, Xiong XP, Jiang LL, et al. (2020) Soluble SORLA enhances neurite outgrowth and regeneration through activation of the EGF Receptor/ERK signaling axis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience |
Qian H, Kang X, Hu J, et al. (2020) Reversing a model of Parkinson's disease with in situ converted nigral neurons. Nature. 582: 550-556 |
Snyder HM, Bain LJ, Brickman AM, et al. (2020) Further understanding the connection between Alzheimer's disease and Down syndrome. Alzheimer's & Dementia : the Journal of the Alzheimer's Association |
Kaplan DR, Mobley WC. (2020) (H)Elping nerve growth factor: Elp1 inhibits TrkA's phosphatase to maintain retrograde signaling. The Journal of Clinical Investigation |
Decourt B, Mobley W, Reiman E, et al. (2020) Recent Perspectives on APP, Secretases, Endosomal Pathways and How they Influence Alzheimer's Related Pathological Changes in Down Syndrome. Journal of Alzheimer's Disease & Parkinsonism. 002 |
Chen XQ, Mobley WC. (2019) Alzheimer Disease Pathogenesis: Insights From Molecular and Cellular Biology Studies of Oligomeric Aβ and Tau Species. Frontiers in Neuroscience. 13: 659 |